Equity Pharmaceutical

Equity Pharmaceuticals is a South African specialty pharmaceutical company that focuses on providing access to niche, unlicensed, and orphan medicines. Founded in 2009 and headquartered in Pretoria, the company specializes in sourcing and distributing essential medications for life-threatening and chronic conditions across Southern Africa. In 2015, it was acquired by the Clinigen Group, enhancing its global reach and capabilities in managed access programs. Equity Pharmaceuticals operates across several therapeutic areas, including oncology, hematology, and intensive care, serving as a critical link in the healthcare supply chain for specialized treatments. The company works closely with regulatory authorities to ensure the ethical and legal supply of unregistered medicines to patients with unmet medical needs.